Hutchmed (china) Share Discussion Threads

[patrick0999] 25/5/2018 12:09

6% drop what happened?

[its the oxman] 25/5/2018 12:03

Something -ve happened?

[nerdofsteel] 25/5/2018 08:57

This HK based Hedge Fund have certainly started to build a substantial holding recently

hxxps://fintel.io/i/karst-peak-capital

[nerdofsteel] 25/5/2018 07:06

What I can say is that when someone buys ADR's or AIM shares marketmakers sometimes make trades between the 2 types of securities to true up the books - there is an explanation about this on the Company's website. The recent drop in the valuation of sterling has helped driveLondon share price, although I agree that there is a disparity. Over the last 2 years occasionally the disparity has been quite large but always comes back into line on a fairly regular basis, helped by the true-up.

[melf] 23/5/2018 14:55

Can anyone explain to me why there is a disparity between the ADRs and UK ords - currently the equivalent of approximately £2? This seems to be a regular occurrence and never in the favour of the UK ords.

[dbadvn] 20/5/2018 17:22

Miri,
You are correct,I sold down a small amount earlier in the year because of the gap in news flow. I started to buy again last month and as long as we are sub 35usd or so I’ll build my position up over the next few months.

[miti 1000] 20/5/2018 12:55

Nerdofsteel , per your post 1437, its always been pretty clear that Fruq CRC approval in China won't happen till late Q3 2018 at the earliest so you had better adjust your time horizon. The pipeline of news in Q4 is pretty good so everything looks rosy. A beigene type of spike might have to wait till we get closer to late Q3.

[nerdofsteel] 18/5/2018 11:38

Mark Slater has made partial disposals regularly over the past 10 years as the share price has increased, so as not to go over the 10% regulatory threshold. That is a nice problem for a Fund Manager to have.

[lauders] 18/5/2018 09:41

Thank you steeplejack! Good to know it is probably just profit taking.

[nerdofsteel] 18/5/2018 07:13

Interestingly, some institutions want to buy large amounts of shares but cannot obtain enough in the market which is interesting. Institutional Investors clearly know the value here and how large the Company will become in the next 5-10 years, which is many multiples of today's valuation.

[nimrod22] 17/5/2018 16:38

Down about 1.8% in the US market as well.
I've sold quite a few shares recently and moved more towards having some cash.
I've hung on to my HCM shares as each time I've sold them in the past (for a gain) they tended to rise even further.
Assuming the pipeline of drugs etc has some winners then there should be more share price rises to come......though drug breakthroughs/approvals can often end in tears....wait and see

[melf] 17/5/2018 15:09

Thanks steeplejack.

[steeplejack] 17/5/2018 15:06

He said nothing to justify weakness.The shares are up 25% over the last two months,admittedly after a sustained fall,but it's probably just a bit of profit taking or analysts muttering "up with events".

[steeplejack] 17/5/2018 13:12

https://www.veracast.com/webcasts/baml/healthcare2018/id76212105613.cfmPresentation last night

[melf] 17/5/2018 12:17

Any ideas why we're 5% down this morning (on very low volume)?

[nerdofsteel] 16/5/2018 06:26

China extends drug patents from 20 to 25 years

That should be good news for us

hxxps://asia.nikkei.com/Politics/China-extends-drug-patents-to-25-years

[nerdofsteel] 15/5/2018 15:53

NDA approval for Fruquintinib CRC in China must surely now be only days or a few weeks away............that will be very material news as our first ever drug to be approved

[nerdofsteel] 14/5/2018 10:28

I knew they were a holder but seem to have increased their holding recently whilst poor old Mark Slater has had to sell part of his to avoid breaking the 10% maximum holding rule ;o-)

[thornyone] 14/5/2018 10:14

After president Trump's pledge to lower US drug prices, perhaps the Chinese authorities will now stop flirting with international drug companies and speed up support for the likes of HCM.

I notice that FCSS's fifth largest holding(Fidelity China Special Situations) is HCM.

[nerdofsteel] 13/5/2018 15:35

President Trump's speech from Friday on lower drug price initiatives - content starts at 40 mins, 3 secs



After the speech the NBO went up by 2%, presumably as the sector liked what they heard, maybe as there will be no direct price controls

[nerdofsteel] 11/5/2018 12:42

Chi-Med to Present at Bank of America Merrill Lynch Annual Health Care Conference - 16th May

hxxps://fintel.io/doc/www.sec.gov/Archives/edgar/data/1648257/000164825718000031/c257-20180511x6k.htm

Webcast available live on the Company website

[nerdofsteel] 09/5/2018 17:30

yes, saw that mad, big volumes always seem to occur ahead of news - it's as if some American institutions "sense" something!

DBADVN - I agree, if we get one over the line (albeit China and not U.S approval) it will validate the fact we are capable of delivering. 30-40% uplift on Fruquintinib approval in CRC??? Let's hope Lilly do not take up their final global option in the summer - we can then go in the U.S!

[mad foetus] 09/5/2018 16:58

Huge trade went through in US.